Vesalius Therapeutics

35 posts

Vesalius Therapeutics banner
Vesalius Therapeutics

Vesalius Therapeutics

@VesaliusTx

Pioneering a revolutionary platform to generate breakthrough treatments for common diseases

Cambridge, MA Katılım Ekim 2021
75 Takip Edilen107 Takipçiler
Vesalius Therapeutics
Vesalius Therapeutics@VesaliusTx·
In Flagship's annual letter, Founder & CEO @NoubarAfeyan reflects on polyintelligence — the synthesis of human, machine, and nature's intelligence. At Vesalius, we’re tapping into polyintelligence to redefine how we think about and treat common diseases #FlagshipFounded.
Flagship Pioneering@FlagshipPioneer

Read or listen to Flagship Pioneering’s 2025 Annual Letter in which Founder & CEO @NoubarAfeyan explores polyintelligence — the synthesis of human, machine, and nature's intelligence, and how it is driving a new renaissance in science and technology: bit.ly/Polyintelligen… Drawing inspiration from Leonardo da Vinci's integrated thinking, Noubar discusses how artificial intelligence will enhance our understanding of nature's adaptive genius in unprecedented ways. He highlights breakthroughs in biotechnology, agriculture, and machine intelligence, and how these polyintelligent innovations can tackle multifaceted challenges in health, climate, and beyond. And for more on how polyintelligence is informing and guiding Flagship’s work, dive into our newly launched Special Section: bit.ly/FlagshipPolyin… #BiggerLeaps #FlagshipStudio #JPM25

English
0
0
1
782
Vesalius Therapeutics
Vesalius Therapeutics@VesaliusTx·
Vesalius redefines how we think about and treat common diseases. Read more about its recent alliance with @GSK to create breakthrough therapies for patients diagnosed with #Parkinson's disease. #press" target="_blank" rel="nofollow noopener">vesaliustx.com/#press
Vesalius Therapeutics tweet media
English
0
0
1
256
Vesalius Therapeutics
Vesalius Therapeutics@VesaliusTx·
Companies pioneering original science are essential to bring about new medicines for patients. We are proud to be part of the #FlagshipFounded ecosystem of companies and the many more to come. bit.ly/4eQfx05
English
0
0
1
220
Vesalius Therapeutics
Vesalius Therapeutics@VesaliusTx·
Done under the auspices of the National Academy of Medicine, this work provides a detailed roadmap to increasing the efficiency, effectiveness, safety, and diversity of clinical trials in the U.S. bit.ly/3VVsQDn
Vesalius Therapeutics tweet media
English
0
0
0
103
Vesalius Therapeutics
Vesalius Therapeutics@VesaliusTx·
Congratulations to our CEO, Christopher Austin (@CPAustinMD), and the rest of the authors of this recent publication outlining 'A Framework for Assessing Clinical Trial Site Readiness'.
English
1
0
1
128
Vesalius Therapeutics
Vesalius Therapeutics@VesaliusTx·
Our CEO, Christopher Austin, was featured in a chapter of @AmyDMarcus’ new book “We the Scientists”. It was only fitting that he show up to support her local event at the Brookline Booksmith this week.
Vesalius Therapeutics tweet mediaVesalius Therapeutics tweet mediaVesalius Therapeutics tweet media
English
0
1
5
569
Vesalius Therapeutics
Vesalius Therapeutics@VesaliusTx·
@AmyDMarcus published an essay in the @WSJ this weekend on how patients are working with researchers in new & creative ways to improve medicine. It’s an idea we hold dear in our work. It was an honor for our CEO Christopher Austin to provide perspective. on.wsj.com/3jZ13TN
Amy Dockser Marcus@AmyDMarcus

We the Scientists is about a powerful idea-- that we, the scientists, doctors, families, patients, regulators, and government officials, can work together to find cures and advance science. @wsj @riverheadbooks

English
0
0
3
37
Vesalius Therapeutics
Vesalius Therapeutics@VesaliusTx·
This paradigm – of including patients earlier and more prominently in the drug development process – is something we’re applying to our work at Vesalius. Check out the book – it's a fantastic read. (2/2)
English
0
0
1
115
Vesalius Therapeutics
Vesalius Therapeutics@VesaliusTx·
@AmyDMarcus’ new book, “We the Scientists,” was officially released today. The book describes a new drug development paradigm that developed when parents, doctors, & researchers joined forces to tackle a devastating disease. Our CEO Christopher Austin was part of that team. (1/2)
Vesalius Therapeutics tweet media
English
1
1
2
441

Keşfet

@NoubarAfeyan @GSK @FlagshipPioneer @MilkenInstitute @WSJ @AmyDMarcus @elonmusk @BarackObama